This is an incredibly interesting (albeit long) take on why we're losing the battle with cancer that appears in Fortune Magazine this month. So many industries would benefit if we began to rethink our short-term, quarter-by-quarter profit margins and spent money on research on things other than data-reproducible, ultimately useless drugs.